Wuhan Neurophth Biotechnology Company

Neurophth is China's first gene therapy company for ophthalmic diseases. As a clinical-stage company, Neurophth is dedicated to discovering and developing gene therapies for patients suffering from blindness and other eye diseases globally.
Industry: Mitochondrial Disorders
Headquarters: China

Visit Website
Register and Claim Ownership